GSDMD and inflammatory bowel disease: Bulek et al. reported that gasdermin D (GSDMD), a crucial pyroptosis effector, collaborates with NEDD4 to release IL-1β-enriched exosomes, thereby triggering inflammation in patients with inflammatory bowel disease [89].